Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies (2015)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS PROSTÁTICAS (DIAGNÓSTICO); HIBRIDIZAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the American Society of Human Genetics
-
ABNT
SQUIRE, Jeremy Andrew et al. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. 2015, Anais.. Baltimore: ASHG, 2015. . Acesso em: 28 dez. 2025. -
APA
Squire, J. A., Picanco-Albuquerque, C. G., Morais, C. L., Carvalho, F. L. F., Peskoe, S. B., Hicks, J. L., et al. (2015). Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. In Abstracts. Baltimore: ASHG. -
NLM
Squire JA, Picanco-Albuquerque CG, Morais CL, Carvalho FLF, Peskoe SB, Hicks JL, Ludkovski O, Fedor H, Humphreys E, Han M, Platz EA, Marzo AM de, Berman DM, Lotan DL. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. Abstracts. 2015 ;[citado 2025 dez. 28 ] -
Vancouver
Squire JA, Picanco-Albuquerque CG, Morais CL, Carvalho FLF, Peskoe SB, Hicks JL, Ludkovski O, Fedor H, Humphreys E, Han M, Platz EA, Marzo AM de, Berman DM, Lotan DL. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. Abstracts. 2015 ;[citado 2025 dez. 28 ] - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Extracellular vesicles: evolving factors in stem cell biology
- The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
